Observations on the Efficacy of L-dopa in Progressive Supranuclear Palsy
Overview
Authors
Affiliations
Therapy and clinical trials in frontotemporal dementia: past, present, and future.
Tsai R, Boxer A J Neurochem. 2016; 138 Suppl 1:211-21.
PMID: 27306957 PMC: 5217534. DOI: 10.1111/jnc.13640.
Treatment of frontotemporal dementia.
Tsai R, Boxer A Curr Treat Options Neurol. 2014; 16(11):319.
PMID: 25238733 PMC: 4920050. DOI: 10.1007/s11940-014-0319-0.
Clinical trials: past, current, and future for atypical Parkinsonian syndromes.
Tsai R, Boxer A Semin Neurol. 2014; 34(2):225-34.
PMID: 24963682 PMC: 4920046. DOI: 10.1055/s-0034-1381739.
Progressive supranuclear palsy: clinical features, pathophysiology and management.
Rajput A, Rajput A Drugs Aging. 2002; 18(12):913-25.
PMID: 11888346 DOI: 10.2165/00002512-200118120-00003.
Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.
Collins S, Ahlskog J, Parisi J, Maraganore D J Neurol Neurosurg Psychiatry. 1995; 58(2):167-73.
PMID: 7876846 PMC: 1073312. DOI: 10.1136/jnnp.58.2.167.